Clozapine rechallenge following clozapine-induced pericarditis

Journal of Clinical Psychiatry

Volumn 71, Issue 7, 2010, Pages 959-961

  Crews, Matthieu P K ^a   Dhillon, Gurbinder S ^a   MacCabe, James H ^b  

^a SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; MELPERONE; OLANZAPINE;

ADOLESCENT; AUDITORY HALLUCINATION; CASE REPORT; DEPRESSION; DRUG DOSE TITRATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEVER; GASTROINTESTINAL SYMPTOM; HUMAN; LETTER; MALE; PARANOID SCHIZOPHRENIA; PATIENT MONITORING; PERICARDIAL EFFUSION; PERICARDITIS; PERSECUTORY DELUSION; PRIORITY JOURNAL; SINUS TACHYCARDIA; THOUGHT DISORDER;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; COOPERATIVE BEHAVIOR; HUMANS; INTERDISCIPLINARY COMMUNICATION; MALE; PATIENT CARE TEAM; PERICARDIAL EFFUSION; PERICARDITIS; REFERRAL AND CONSULTATION; RETREATMENT; SCHIZOPHRENIA, PARANOID; TACHYCARDIA, SINUS;

EID: 77955300647     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.09l05692yel     Document Type: Letter

References (18)

1. Kilian JG, Kerr K, Lawrence C, et al. Myocarditis and cardiomyopathy associated with clozapine. Lancet. 1999;354(9193):1841-1845.
2. Zaponex (clozapine). Summary of Product Characteristics. http://www.ztas.co.uk/pdf/Summary-Of-Product-Characteristics.pdf. Published June 2004. Accessed April 26, 2010.
3. Aronson J. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. 15th ed. Amsterdam, Holland: Elsevier Science; 2006.
4. Wehmeier PM, Heiser P, Remschmidt H. Myocarditis, pericarditis and cardiomyopathy in patients treated with clozapine. J Clin Pharm Ther. 2005;30(1):91-96. (Pubitemid 41602097)
5. Bhatti MA, Zander J, Reeve E. Clozapine-induced pericarditis, pericardial tamponade, polyserositis, and rash [letter]. J Clin Psychiatry. 2005;66(11):1490-1491.
6. Branik E, Nitschke M. Pericarditis and polyserositis as a side effect of clozapine in an adolescent girl. J Child Adolesc Psychopharmacol. 2004;14(2):311-314. (Pubitemid 38988796)
7. Körtner K, Neuhaus AH, Schürer F, et al. Eosinophilia indicating subclinical clozapine-induced pericarditis [letter]. J Clin Psychiatry. 2007;68(7):1147-1148. (Pubitemid 47340342)
8. Lim A, Sivakumaran P, Israel M. Clozapine-associated polyserositis. N Z Med J. 2003;116(1184):U651.
9. Malhotra S, Franco K, Tomford JW, et al. Polyserositis, acute withdrawal, and relapse after abrupt clozapine discontinuation. Psychosomatics. 2002;43(5):418-420.
10. Murko A, Clarke S, Black DW. Clozapine and pericarditis with pericardial effusion [letter]. Am J Psychiatry. 2002;159(3):494. (Pubitemid 34184756)
11. Raju P, Rao GK, Davis G. Pericardial effusion in patients with schizophrenia: are they on clozapine? Emerg Med J. 2008;25(6):383-384. (Pubitemid 351833377)
12. Rathore S, Masani ND, Callaghan PO. Clozapine-induced effuso-constrictive pericarditis. Case report and review of the literature. Cardiology. 2007;108(3):183-185. (Pubitemid 47525216)
13. Schonfeldt-Lecuona C, Connemann BJ. Sweet's syndrome and polyserositis with clozapine [letter]. Am J Psychiatry. 2002;159(11):1947. (Pubitemid 35283268)
14. Waller H, Porter R, Ritz S, et al. Late occurrence of clozapine-associated polyserositis [letter]. Int J Neuropsychopharmacol. 2007;10(1):147-148. (Pubitemid 46122763)
15. Kay SE, Doery J, Sholl D. Clozapine associated pericarditis and elevated troponin I. Aust N Z J Psychiatry. 2002;36(1):143-144. (Pubitemid 34285014)
16. Daly JM, Goldberg RJ, Braman SS. Polyserositis associated with clozapine treatment [letter]. Am J Psychiatry. 1992;149(9):1274-1275.
17. Wehmeier PM, Schüler-Springorum M, Heiser P, et al. Chart review for potential features of myocarditis, pericarditis, and cardiomyopathy in children and adolescents treated with clozapine. J Child Adolesc Psychopharmacol. 2004;14(2):267-271. (Pubitemid 38988792)
18. Berk M, Fitzsimons J, Lambert T, et al. Monitoring the safe use of clozapine: a consensus view from Victoria, Australia. CNS Drugs. 2007;21(2):117-127. (Pubitemid 46247817)